Fennec Pharmaceuticals Inc.

(FRX.WT:CA)

By |

Profile

Fennec Pharmaceuticals Inc is a biotechnology company developing Sodium Thiosulfate, a chemo-protectant against hearing loss associated with platinum-based anti-cancer agents in children.

Issuer Information

NAICS: Pharmaceutical P
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 0.01 52 Wk Low 0.01
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 44,346,460.00 EPS (TTM) N/A PE Ratio N/A Exchange TSX